The latest clearance allows MIM Software to calculate radionuclide absorbed doses using a Monte Carlo method. Dosimetry will be available through the Dose Planning Method (DPM) and MIM SurePlan MRT, MIM Software’s solution for automating and standardizing dosimetry in theranostics.

Dosimetry in radiotherapy helps estimate the amount of dose that will be absorbed by normal tissues and tumors to anticipate the biological effects of radiation. Radiopharmaceutical therapy and theranostics are increasingly used to treat cancer, so the need to use dosimetry to personalize care is also increasing.